Max Planck Institute and Cellomics Announce Collaboration for High Content Screening Development
03-Nov-2005 -
The Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), located in Dresden, Germany, and Cellomics, a unit of Fisher Biosciences, recently announced a joint collaboration in the field of High Content Screening (HCS). The institute serves as a hub for numerous academic-industry ...
biology
biotechnology
collaborations
+3